Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991
With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasi...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
1994
|
| Schriftenreihe: | Developments in Oncology
74 |
| Schlagworte: | |
| Online-Zugang: | DE-355 URL des Erstveröffentlichers |
| Zusammenfassung: | With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified. The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy. The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach |
| Beschreibung: | 1 Online-Ressource (XI, 403 p) |
| ISBN: | 9781461526100 |
| DOI: | 10.1007/978-1-4615-2610-0 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046146749 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1994 xx o|||| 00||| eng d | ||
| 020 | |a 9781461526100 |9 978-1-4615-2610-0 | ||
| 024 | 7 | |a 10.1007/978-1-4615-2610-0 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4615-2610-0 | ||
| 035 | |a (OCoLC)1119094416 | ||
| 035 | |a (DE-599)BVBBV046146749 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XI 7005 |0 (DE-625)153024:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Anticancer Drug Discovery and Development: Natural Products and New Molecular Models |b Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 |c edited by Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker |
| 246 | 1 | 3 | |a Proceedings of Second Drug Discovery and Development Symposium, Traverse City, Michigan, June 27--29, 1991 |
| 264 | 1 | |a Boston, MA |b Springer US |c 1994 | |
| 300 | |a 1 Online-Ressource (XI, 403 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Developments in Oncology |v 74 | |
| 520 | |a With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified. The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy. The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Toxicology | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Naturheilmittel |0 (DE-588)4288415-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Traverse City Mich. |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Naturheilmittel |0 (DE-588)4288415-9 |D s |
| 689 | 0 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 1 | |a Naturheilmittel |0 (DE-588)4288415-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 2 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Valeriote, Frederick A. |4 edt | |
| 700 | 1 | |a Corbett, Thomas H. |4 edt | |
| 700 | 1 | |a Baker, Laurence H. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461361183 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792329282 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461526117 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-2610-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-031526934 | |
| 966 | e | |u https://doi.org/10.1007/978-1-4615-2610-0 |l DE-355 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1823607507884441600 |
|---|---|
| adam_text | |
| any_adam_object | |
| author2 | Valeriote, Frederick A. Corbett, Thomas H. Baker, Laurence H. |
| author2_role | edt edt edt |
| author2_variant | f a v fa fav t h c th thc l h b lh lhb |
| author_facet | Valeriote, Frederick A. Corbett, Thomas H. Baker, Laurence H. |
| building | Verbundindex |
| bvnumber | BV046146749 |
| classification_rvk | XI 7005 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4615-2610-0 (OCoLC)1119094416 (DE-599)BVBBV046146749 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4615-2610-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zcb4500</leader><controlfield tag="001">BV046146749</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1994 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461526100</subfield><subfield code="9">978-1-4615-2610-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-2610-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4615-2610-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119094416</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146749</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7005</subfield><subfield code="0">(DE-625)153024:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticancer Drug Discovery and Development: Natural Products and New Molecular Models</subfield><subfield code="b">Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991</subfield><subfield code="c">edited by Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Proceedings of Second Drug Discovery and Development Symposium, Traverse City, Michigan, June 27--29, 1991</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 403 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Developments in Oncology</subfield><subfield code="v">74</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified. The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy. The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Naturheilmittel</subfield><subfield code="0">(DE-588)4288415-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Traverse City Mich.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Naturheilmittel</subfield><subfield code="0">(DE-588)4288415-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Naturheilmittel</subfield><subfield code="0">(DE-588)4288415-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valeriote, Frederick A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Corbett, Thomas H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baker, Laurence H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461361183</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792329282</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461526117</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-2610-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526934</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-2610-0</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 Traverse City Mich. gnd-content |
| genre_facet | Konferenzschrift 1991 Traverse City Mich. |
| id | DE-604.BV046146749 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-09T19:00:43Z |
| institution | BVB |
| isbn | 9781461526100 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526934 |
| oclc_num | 1119094416 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XI, 403 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Springer US |
| record_format | marc |
| series2 | Developments in Oncology |
| spelling | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 edited by Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker Proceedings of Second Drug Discovery and Development Symposium, Traverse City, Michigan, June 27--29, 1991 Boston, MA Springer US 1994 1 Online-Ressource (XI, 403 p) txt rdacontent c rdamedia cr rdacarrier Developments in Oncology 74 With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified. The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy. The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach Oncology Cancer Research Pharmacology/Toxicology Oncology Toxicology Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Naturheilmittel (DE-588)4288415-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Traverse City Mich. gnd-content Krebs Medizin (DE-588)4073781-0 s Naturheilmittel (DE-588)4288415-9 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Cytostatikum (DE-588)4068347-3 s Valeriote, Frederick A. edt Corbett, Thomas H. edt Baker, Laurence H. edt Erscheint auch als Druck-Ausgabe 9781461361183 Erscheint auch als Druck-Ausgabe 9780792329282 Erscheint auch als Druck-Ausgabe 9781461526117 https://doi.org/10.1007/978-1-4615-2610-0 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 Oncology Cancer Research Pharmacology/Toxicology Oncology Toxicology Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd Naturheilmittel (DE-588)4288415-9 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4068347-3 (DE-588)4073781-0 (DE-588)4288415-9 (DE-588)1071861417 |
| title | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 |
| title_alt | Proceedings of Second Drug Discovery and Development Symposium, Traverse City, Michigan, June 27--29, 1991 |
| title_auth | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 |
| title_exact_search | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 |
| title_full | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 edited by Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker |
| title_fullStr | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 edited by Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker |
| title_full_unstemmed | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 edited by Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker |
| title_short | Anticancer Drug Discovery and Development: Natural Products and New Molecular Models |
| title_sort | anticancer drug discovery and development natural products and new molecular models proceedings of the second drug discovery and development symposium traverse city michigan usa june 27 29 1991 |
| title_sub | Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991 |
| topic | Oncology Cancer Research Pharmacology/Toxicology Oncology Toxicology Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd Naturheilmittel (DE-588)4288415-9 gnd |
| topic_facet | Oncology Cancer Research Pharmacology/Toxicology Oncology Toxicology Arzneimittelentwicklung Cytostatikum Krebs Medizin Naturheilmittel Konferenzschrift 1991 Traverse City Mich. |
| url | https://doi.org/10.1007/978-1-4615-2610-0 |
| work_keys_str_mv | AT valeriotefredericka anticancerdrugdiscoveryanddevelopmentnaturalproductsandnewmolecularmodelsproceedingsoftheseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganusajune27291991 AT corbettthomash anticancerdrugdiscoveryanddevelopmentnaturalproductsandnewmolecularmodelsproceedingsoftheseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganusajune27291991 AT bakerlaurenceh anticancerdrugdiscoveryanddevelopmentnaturalproductsandnewmolecularmodelsproceedingsoftheseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganusajune27291991 AT valeriotefredericka proceedingsofseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganjune27291991 AT corbettthomash proceedingsofseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganjune27291991 AT bakerlaurenceh proceedingsofseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganjune27291991 |